July 8, 2024- Amsino Medical Group Company (“Amsino”), a global provider of medical consumable devices, is pleased to announce the closing of a substantial investment by Novo Tellus, a leading investment firm specialising in long-term investments in the global supply chain. Novo Tellus is deeply familiar with Amsino, having previously partnered with Amsino to create substantial growth between 2011 and 2017. Amsino’s management team and Novo Tellus aim to work closely again to grow Amsino’s global production, R&D, and commitment to quality to deliver better and better solutions to customers around the world.
The investment was made with all equity and no debt from Novo Tellus investment funds, and closed in June 2024, with Novo Tellus and Amsino already working actively to build the Company’s future together.